Archive for the 'Drug Regulators and Conflicts of Interest' Category

16
Jan

Health Canada is not doing enough to protect our children from Paxil pusher GlaxoSmithKline!

If SSRI were prescribed for clinical depression and the diagnosis was carefully defined then we would not have this problem.  What is happening and has been for a long time is that doctors have exchanged clinical treatment for a prescription pad.  In addition to this pharmaceutical companies have been injecting themselves in the doctor patient [...]

15
Jan

Canadian frustrated with Health Canada

I’ve just been copied in on an email sent to Health Canada from a very concerned Canadian citizen. They have given me permission to post the email on my blog. The person’s name and email address have been redacted at their request:
http://fiddaman.blogspot.com/2009/01/concerned-canadian-citizen-email-to.html
Dear Health Canada,
It is very obvious that Paxil poses a serious threat to the [...]

07
Oct

The two women exposed years of corruption and deception at GlaxoSmithKline, the company that manufactures Paxil, an anti-depressant prescribed to children

October 7, 2008

A story worth telling
Alumnus and Prof. Alison Bass’ (AMST) new book describes her revolutionary findings on corrupt pharmaceutical companies
by Casey Nilsson

Features | 10/7/08
Posted online at 2:50 AM EST on 10/7/08
“To be a journalist,” says Alison Bass (AMST), “you’ve got to have thick skin.”
Bass’ first book, Side Effects: A Prosecutor, a Whistleblower, and [...]

07
Oct

Charles Nemeroff is a Dirty Boy!

The psychiatry world is belatedly exhibiting outrage toward a man whose ability to lure pharma cash seems to know no bounds. He may be the textbook case of a key opinion leader. Of course, I speak of Charles “Bling Bling” Nemeroff. Rather than list the many questionable at best behaviors he has exhibited, each of [...]

31
Jul

Senator Chuck Grassley Is Asking GSK Some Important Questions! Grassley is my heroe!

Immediate Release
Thursday, June 12, 2008
Grassley seeks FDA scrutiny of Paxil and suicide risk
 
 
WASHINGTON – Senator Chuck Grassley has asked the Food and Drug Administration
to carefully scrutinize information it received from drug maker GlaxoSmithKline about the
anxiety disorder drug Paxil, based on the contents of a newly available report about the drug’s
risk for suicide among adults. Grassley [...]

31
Jul

From the home office of GlaxoSmithKline’s CEO:

I read this and found it quite fitting. Congrats to the author. What a wonderful mind you have. Well done!

31
Jul

CONFLICTS OF INTEREST AND THE SAFETY OF SSRIs

INFORMATION MANAGEMENT, CONFLICTS OF INTEREST
AND THE SAFETY OF SSRIs

Charles Medawar – Social Audit, August 2003
The Medicines Control Agency (MCA) ceased to exist on April 1st 2003, though little changed when it was reconstituted as the Medicines and Healthcare Products Regulatory Agency. In the MHRA the regulation of drugs and medical devices are now under the [...]

© 2010 Death by Paxil @ Euchred!

Designed by Top 10 Web Hosting -- Made free by Pop Art and TFT Monitors